Fig. 4

SHAP dependence analysis stratified by T stage. (A1–A4) maximum tumor diameter (MTD) dependence plots for T1–T4 stages. (B1–B4) platelet-to-albumin ratio (PAR) dependence plots for T1–T4 stages. (C1–C4) platelet-to-lymphocyte ratio (PLR) dependence plots for T1–T4 stages. (D1–D4) carcinoembryonic antigen (CEA) dependence plots for T1–T4 stages. (E1–E4) fibrinogen (FIB) dependence plots for T1–T4 stages. (F1–F4) systemic immune-inflammation index (SII) dependence plots for T1–T4 stages. Color coding represents SHAP values. Each plot demonstrates how feature values influence SHAP values (model predictions) within specific T stage groups.